Evidence map›Paper›PMID 29882025›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2018

Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study.

Allan 'Ben' Smith, Louise Sharpe, Belinda Thewes, Jane Turner, Jemma Gilchrist, Joanna E Fardell, Afaf Girgis, Stephanie Tesson, Joseph Descallar, Melanie L Bell and 3 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04287218 (A Randomized Controlled Trial Comparing the Efficacy of Therapist Guided Internet-delivered Cognitive Therapy), which is not on this map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04287218 nacompletednot on this mapstarted 2023, after this paper: background citation

A Randomized Controlled Trial Comparing the Efficacy of Therapist Guided Internet-delivered Cognitive Therapy (TG-iConquerFear) With Augmented Treatment as Usual in Reducing Fear of Cancer Recurrence in Danish Colorectal Cancer Survivors

TypeinterventionalSponsorVejle HospitalRan2023 to 2026Enrolled95ConditionsFear of Cancer Recurrence, Colorectal Cancer, Anxiety, Health AnxietyArmsTG-iConquerFear, aTAU
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Fear of cancer recurrence among cancer survivors in South Korea: high prevalence and predictors of clinical FCR.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Cascading pathways from physical symptom burden to distress in adults with cancer.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Socioeconomic inequality of health-related quality of life in cancer survivors in South Korea.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  15. Article
  16. Article
  17. Assessing the fear of recurrence using the Cancer Worry Scale in a sample of Italian breast cancer survivors.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Review
  18. Article
  19. Article
  20. Patient competence in the context of cancer: its dimensions and their relationships with coping, coping self-efficacy, fear of progression, and depression.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Allan 'Ben' SmithPsycho-Oncology Co-operative Research Group (PoCoG), University of Sydney, Sydney, Australia. ben.smith@unsw.edu.au.ORCID http://orcid.org/0000-0002-2496-7369
Louise SharpeSchool of Psychology, University of Sydney, Sydney, Australia.
Belinda ThewesPsycho-Oncology Co-operative Research Group (PoCoG), University of Sydney, Sydney, Australia.
Jane TurnerMental Health Centre, Faculty of Medicine, University of Queensland, Brisbane, Australia.
Jemma GilchristCrown Princess Mary Cancer Centre, Breast Cancer Institute, Westmead Hospital, Sydney, Australia.
Joanna E FardellPsycho-Oncology Co-operative Research Group (PoCoG), University of Sydney, Sydney, Australia.
Afaf GirgisCentre for Oncology Education and Research Translation (CONCERT), Ingham Institute for Applied Medical Research, South Western Sydney Clinical School, University of New South Wales, Sydney, Australia.
Stephanie TessonPsycho-Oncology Co-operative Research Group (PoCoG), University of Sydney, Sydney, Australia.
Joseph DescallarCentre for Oncology Education and Research Translation (CONCERT), Ingham Institute for Applied Medical Research, South Western Sydney Clinical School, University of New South Wales, Sydney, Australia.
Melanie L BellPsycho-Oncology Co-operative Research Group (PoCoG), University of Sydney, Sydney, Australia.
Jane BeithDepartment of Medical Oncology, Chris O'Brien Lifehouse, Missenden Rd, Camperdown, NSW, Australia.
Phyllis ButowPsycho-Oncology Co-operative Research Group (PoCoG), University of Sydney, Sydney, Australia.
ConquerFear Authorship Group
The University of Sydney · AUThe University of Queensland · AUUniversity of Arizona · US

Funding

beyondblue NACancer Australia NACancer Institute NSW NANational Breast Cancer Foundation NANational Health and Medical Research Council NA
6 · The paper itself

Abstract

purposeDespite the prevalence of fear of cancer recurrence (FCR), understanding of factors underlying clinically significant FCR is limited. This study examined factors associated with greater FCR morbidity, according to a cognitive processing model, in cancer survivors who screened positively for clinically significant FCR seeking psychological treatment through the ConquerFear trial.

methodsParticipants had completed treatment for breast, colorectal or melanoma cancer 2 months to 5 years previously and scored ≥ 13/36 on the Fear of Cancer Recurrence Inventory-Short Form (FCRI-SF). Hierarchical regression analyses examined associations between demographic, medical and psychological variables, namely metacognitions (MCQ-30), post-traumatic stress symptoms (IES-R) and FCR (FCRI total score).

resultsTwo hundred and ten (95%) of the 222 cancer survivors who consented to the ConquerFear trial completed the baseline questionnaire. Participants were predominantly (89%) breast cancer survivors. The final regression model accounted for 68% of the variance in FCR (demographic and medical variables 13%, metacognitions 26%, post-traumatic stress symptoms 28%). Negative metacognitive beliefs about worry and intrusive post-traumatic stress symptoms were significant individual correlates of FCR, but negative beliefs about worry did not significantly moderate the impact of intrusions on FCR morbidity.

conclusionsResults provide partial support for the cognitive processing model of FCR. Psychological factors were found to play an important role in FCR morbidity after controlling for demographic/medical factors. More intrusive thoughts and negative beliefs about worry were strong independent predictors of FCR morbidity. Cancer survivors with clinically significant FCR may benefit from assessment for intrusive thoughts and metacognitions and delivery of trauma- and/or metacognitive-based interventions accordingly.

Indexed as

AdultAgedAnxietyBreast NeoplasmsCancer SurvivorsCognitionColorectal NeoplasmsDemographyFearFemaleHumansMaleMelanomaMiddle AgedMorbidityNeoplasm Recurrence, LocalCancerFear of cancer recurrenceMetacognitionsPost-traumatic stressSupportive careSurvivorship

Identifiers

PMID29882025
OpenAlexW2807617718

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.